XML 67 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Payments (Tables)
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Share-based compensation expense included in condensed consolidated statements of income
The following table summarizes share-based compensation expense included in our condensed consolidated statements of income:
For the Three Months Ended September 30,For the Nine Months Ended September 30,
(In millions)2021202020212020
Research and development $19.5 $14.6 $72.2 $63.1 
Selling, general and administrative42.6 25.0 127.8 98.4 
Subtotal62.1 39.6 200.0 161.5 
Capitalized share-based compensation costs (1.9)(1.9)(6.3)(4.9)
Share-based compensation expense included in total cost and expense60.2 37.7 193.7 156.6 
Income tax effect(10.9)(5.4)(35.8)(25.7)
Share-based compensation expense included in net income attributable to Biogen Inc.$49.3 $32.3 $157.9 $130.9 
Summary of share-based compensation expense associated with each of our share-based compensating programs
The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:
For the Three Months Ended September 30,For the Nine Months Ended September 30,
(In millions)2021202020212020
Market stock units$9.7 $5.5 $35.5 $32.0 
Time-vested restricted stock units38.8 35.3 121.9 107.3 
Cash settled performance units— — — (1.7)
Performance units— — — (0.1)
Performance stock units settled in stock4.9 (8.4)14.2 4.0 
Performance stock units settled in cash4.4 4.1 13.9 9.0 
Employee stock purchase plan4.3 3.1 14.5 11.0 
Subtotal62.1 39.6 200.0 161.5 
Capitalized share-based compensation costs(1.9)(1.9)(6.3)(4.9)
Share-based compensation expense included in total cost and expense$60.2 $37.7 $193.7 $156.6